Skip to main content

Starling Oncology, Inc 10-K for FY2022

Starling Oncology, Inc. (STLN)

10-K 2023-03-16 For: 2022-12-31
View Original
Added on April 06, 2026

About this 10-K

Starling Oncology, Inc filed this 10-K on March 16, 2023, covering the fiscal year ended December 31, 2022 (FY2022).

Headline figures

Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$252.48M
up 24.4% from $203M a year earlier
Net income
$152K
compared with a net loss of $10.93M a year earlier
Diluted EPS
-$0.21
compared with -$0.16 a year earlier